Foresee Pharmaceuticals Camcevi,…
Foresee Pharmaceuticals Camcevi, currently approved as a treatment for advanced [...]
Foresee Pharmaceuticals Camcevi, currently approved as a treatment for advanced [...]
The emergence of next-generation KRAS G12C inhibitors has led Verastem [...]
Although it looked to be lights out for InflaRx’s C5a [...]
To get its hands on the Emeryville, California-based company and [...]
With a Christmas Eve thumbs up for Yartemlea, the FDA [...]
Of the top 10 biopharma M&A deals of 2025, six [...]
A court in Baltimore has ordered Johnson & Johnson to [...]
A patient in an open label extension study of Pfizer’s [...]
Neurocrine’s Ingrezza, approved to treat certain uncontrolled movements, failed to [...]
Drug pricing, layoffs, personnel moves and other topics drove reader [...]